79
Participants
Start Date
July 3, 2018
Primary Completion Date
February 28, 2025
Study Completion Date
February 28, 2025
Formal study using hyperpolarized 13C-pyruvate injection
Administration at two visits 1) after completion of cardiotoxic therapy and 2) 1 to 6 months after the first time point following medical therapy (SOC)
Feasible study using hyperpolarized 13C-pyruvate injection
Administration at two visits: 1) baseline MRI before administration of cardiotoxic therapy and 2) after completion of cardiotoxic therapy
UT Southwestern - Advanced Imaging Research Center, Dallas
University of Texas Southwestern Medical Center
OTHER